Michael Scott Salka
2017
In 2017, Michael Scott Salka earned a total compensation of $704.4K as former Chief Executive Officer at AmpliPhi Biosciences, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,051 |
|---|---|
| Option Awards | $84,693 |
| Salary | $227,769 |
| Other | $247,917 |
| Total | $704,430 |
Salka received $247.9K in other compensation, accounting for 35% of the total pay in 2017.
Salka also received $144.1K in non-equity incentive plan, $84.7K in option awards and $227.8K in salary.
Rankings
In 2017, Michael Scott Salka's compensation ranked 10,586th out of 14,666 executives tracked by ExecPay. In other words, Salka earned more than 27.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,586 out of 14,666 | 28th |
Division Manufacturing | 4,121 out of 5,772 | 29th |
Major group Chemicals And Allied Products | 1,470 out of 2,075 | 29th |
Industry group Drugs | 1,201 out of 1,731 | 31st |
Industry Biological Products, Except Diagnostic Substances | 217 out of 313 | 31st |
Source: SEC filing on November 9, 2018.
Salka's colleagues
We found five more compensation records of executives who worked with Michael Scott Salka at AmpliPhi Biosciences in 2017.
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Steve Martin
AmpliPhi Biosciences
Chief Financial Officer
2017
Paul Grint
AmpliPhi Biosciences
Chief Executive Officer
2017
Paul Grint
AmpliPhi Biosciences